Estrella Immunopharma, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
03/29/2024 | Q3 2023 | -$0.01 | $0 | |||
12/30/2023 | Q2 2023 | -$0.03 | $0 | |||
09/29/2023 | Q1 2023 | -$1.78 | $0 | |||
06/28/2023 | Q4 2022 | -$0.03 | $0 | |||
03/29/2023 | Q3 2022 | -$0.03 | $0 | |||
12/30/2022 | Q2 2022 | -$1.18 | $0 | |||
09/28/2022 | Q1 2022 | -$0.06 | $0 | |||
06/29/2022 | Q4 2021 | -$0.03 | $0 | |||
03/30/2022 | Q3 2021 | -$0.03 | $0 | |||
12/30/2021 | Q2 2021 | -$0.00 | $0 | |||
09/28/2021 | Q1 2021 | -$0.02 | $0 |
Estrella Immunopharma, Inc. Earnings: Frequently Asked Questions
-
When is Estrella Immunopharma, Inc.'s earnings date?
Estrella Immunopharma, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, September 17th, 2024 based off last year's report dates.
-
How can I listen to Estrella Immunopharma, Inc.'s earnings conference call?
The conference call for Estrella Immunopharma, Inc.'s latest earnings report can be listened to online.
-
How can I read Estrella Immunopharma, Inc.'s conference call transcript?
The conference call transcript for Estrella Immunopharma, Inc.'s latest earnings report can be read online.
-
How much profit does Estrella Immunopharma, Inc. generate each year?
Estrella Immunopharma, Inc. (:ESLA) has a recorded net income of $0. Estrella Immunopharma, Inc. has generated $-0.17 earnings per share over the last four quarters.
-
What is Estrella Immunopharma, Inc.'s price-to-earnings ratio?
Estrella Immunopharma, Inc. (:ESLA) has a price-to-earnings ratio of -11.27 and price/earnings-to-growth ratio is -0.27.